Finland is a leading country in cancer care and diagnostics
More and more patients are coming to Finland to seek better cancer treatments. Patients’ freedom to choose where they get treated has increased through the EU patient directive.
At Docrates Cancer Center the freedom of choice has been noted: So far, we have treated patients from over 60 countries. Foreign patients make up one fifth of our patients.
As one of the largest healthcare service exporters in Finland, we can proudly say that we are the engine of Finnish health tourism!
Finnish cancer treatment is among the best in Europe and in the world
On a European and global scale, Finland is profiled as a country with first-class cancer care. This is illustrated by the latest CONCORD-3 study, which sheds light on 5-year survival rates for various cancers worldwide (CONCORD-3: Global surveillance of trends in cancer survival 2000–14. Lancet 2018; 391: 1023–75).
According to the study, the 5-year survival rate for most cancers in Finland is among the highest in the world. In terms of 5-year survival rate, we are the third best country in Europe in treating prostate, breast and adult’s brain cancer. For example, 93.2 % of patients with prostate cancer live five years after the diagnosis.
The CONCORD-3 includes data from 37.5 million patients diagnosed with cancer between the years 2000 and 2014. The study covers 71 countries and regions.
Figure 1. Five years after prostate cancer diagnosis, 93.2 % of the patients in Finland are alive.
Figure 2. Five years after breast cancer diagnosis, 88.5 % of the patients in Finland are alive.
Figure 3. Five years after (adult’s) brain cancer diagnosis, 37.6 % of the patients in Finland are alive.
Figure 4. Five years after colon cancer diagnosis, 64.9 % of the patients in Finland are alive.
Finnish cancer research is the most cited in the world
Cancer research has traditionally been of very high quality in Finland. If we look at the average number of citations per clinical cancer publication, we can say that Finland is the number one country in cancer research. Each Finnish cancer article receives an average of 26.4 citations:
Our team will gladly help our international patients at tel + 358 10 773 2010 (Mon – Fri 8:00 – 16:00) or e-mail: email@example.com.
After we have received the medical documentation, our multidisciplinary team of medical experts examines it and makes your personal diagnostics plan.
Internal radiotherapy is an effective method of treatment for metastatic prostate cancer
14.3.2023 | Docrates Cancer Center studied the effectiveness of 177Lu-PSMA treatment with a 4-week treatment interval for patients with metastatic...Read more
The number of insured patients has more than tripled in five years
9.3.2023 | In 2022, nearly 30% of revenue generated by Docrates Cancer Center’s Finnish patients came from insurance company customers,...Read more
Docrates joins EAU23 – Europe’s biggest urological event 10 – 13 March, 2023 in Milan
8.3.2023 | Docrates Cancer Center participates to EAU23 – the Europe’s biggest urological event, which will be held on 10-13...Read more
COVID-19 – Information and guidelines
14.3.2023 | In the aftermath of the COVID-19 pandemic, we have abandoned the most robust protective measures. On this page,...Read more
Why come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.
Mon-Thu 8 am-6 pm, Fri 8 am-4 pm (local time)